![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1873-4316|17|1|30-41
ISSN: 1389-2010
Source: Current Pharmaceutical Biotechnology, Vol.17, Iss.1, 2016-01, pp. : 30-41
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Management of acute myeloid leukaemia
By Rule Simon Poirer Veronique Singer Charles
Clinical Medicine, Vol. 1, Iss. 4, 2001-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Doxorubicin/etoposide/ifosfamide: Therapy-related acute myeloid leukaemia: case report
Reactions Weekly, Vol. 1, Iss. 1287, 2010-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Gemtuzumab Ozogamicin: A Review of its Use in Acute Myeloid Leukaemia
By Fenton Caroline Perry Caroline M.
Drugs, Vol. 65, Iss. 16, 2005-01 ,pp. :